The tumoricidal and TMZ-sensitizing effects of BI2536 were uniformly observed across Ink4a/Arf(−/−) EGFRvIII glioblastoma clones that acquired independent resistance mechanisms to EGFR inhibitors, suggesting these resistant clones retain oncogenic stress that required PLK1 compensation. This evidence concerns the gene CDKN2A and glioblastoma.